Launching our most comprehensive test and expanding into new global markets
January 31, 2024 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Jan. 31, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE), is at the forefront in personalised predictive genomics, reshaping the healthcare landscape with...
Global Optogenetics Market Report 2024-2033: Emerging Trends in Tools & Technologies, Pharma Collaborations, Drug Discovery & Development Integration, and Non-Neural Cell Type Applications
January 18, 2024 06:53 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Optogenetics Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global optogenetics market has grown rapidly in...
GeneType's Groundbreaking Saliva Test Transforms Early Disease Detection, Paving the Way for Personalized Wellness
December 14, 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies (GTG) is proud to provide details of a series of recent transformative initiatives. Our commitment to advancing early...
Genetic Technologies Limited Announces Ordinary Share Consolidation and ADS Ratio Change
December 12, 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
Global Gene Therapy Market Poised for Remarkable 9.26% CAGR, Expected to Reach USD 10.13 Billion by 2028
October 31, 2023 08:48 ET
|
Research and Markets
Dublin, Oct. 31, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
Gene Business Update: Private Hospital Partnership; Expanded Multi-Test for Australian Market and Commercial Partner for Cancer Clinical Trial
October 30, 2023 08:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, ”Company”, “GTG”), a global leader in guideline-driven genomics-based testing in health,...
Global Paternity & Relationship Testing Services Market Research Report 2023-2027: Genomic Revolution Expands Beyond Paternity Testing - New Growth Opportunities Emerge
October 20, 2023 04:53 ET
|
Research and Markets
Dublin, Oct. 20, 2023 (GLOBE NEWSWIRE) -- The "Paternity & Relationship Testing Services. Global Market Forecasts for Applications and Technologies with Executive and Consultant Guides. 2023 to...
GeneType Predicting Risk of Pancreatic Cancer: Major Breakthrough in Early Detection and Treatment
October 18, 2023 08:30 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Oct. 18, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and...
GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
September 27, 2023 09:00 ET
|
Genetic Technologies Ltd
MELBOURNE, Australia, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”) – a global leader in genomics-based tests in health, wellness and...
Global Viral Vector Partnering Deal Terms and Agreements Analysis Report & Directory 2023: Access to Over 400 Deals and Corresponding Documents Signed Since 2016
August 04, 2023 09:08 ET
|
Research and Markets
Dublin, Aug. 04, 2023 (GLOBE NEWSWIRE) -- The "Global Viral Vector Partnering Terms and Agreements 2016 to 2023" report has been added to ResearchAndMarkets.com's offering. The Global Viral...